Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin C Boucher

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor Design Today and TomorrowJustin C Boucher, Marco L Davila
Cancers|March 10, 2022
Emerging CAR T Cell Strategies for the Treatment of AMLParesh Vishwasrao, Gongbo Li, Justin C Boucher, et al.
Immunologic Research|December 3, 2013
B-lymphocyte tolerance and effector function in immunity and autoimmunityWasif N Khan, Jacqueline A Wright, Eden Kleiman, et al.
Infection and Immunity|January 10, 2018
The eIF2α Kinase Heme-Regulated Inhibitor Protects the Host from Infection by Regulating Intracellular Pathogen TraffickingWael Bahnan, Justin C Boucher, Petoria Gayle, et al.
JCI Insight|September 21, 2018
4-1BB enhancement of CAR T function requires NF-κB and TRAFsGongbo Li, Justin C Boucher, Hiroshi Kotani, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 15, 2022
Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting CellsJustin C Boucher, Bin Yu, Gongbo Li, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 14, 2019
Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting CellsBishwas Shrestha, Yongliang Zhang, Bin Yu, et al.
Scientific Reports|March 12, 2026
CD28 co-stimulatory domain enhances efficacy of CER T cell therapy compared to 4-1BB in an ovarian cancer mouse modelNolan J Beatty, Min Ma, Payal Goala, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cellsEmiliano Roselli, Justin C Boucher, Gongbo Li, et al.
Journal of Biomedical Science|July 11, 2024
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damageHiroshi Kotani, Hiroko Oshima, Justin C Boucher, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor Design Today and TomorrowJustin C Boucher, Marco L Davila
Cancers|March 10, 2022
Emerging CAR T Cell Strategies for the Treatment of AMLParesh Vishwasrao, Gongbo Li, Justin C Boucher, et al.
Immunologic Research|December 3, 2013
B-lymphocyte tolerance and effector function in immunity and autoimmunityWasif N Khan, Jacqueline A Wright, Eden Kleiman, et al.
Infection and Immunity|January 10, 2018
The eIF2α Kinase Heme-Regulated Inhibitor Protects the Host from Infection by Regulating Intracellular Pathogen TraffickingWael Bahnan, Justin C Boucher, Petoria Gayle, et al.
JCI Insight|September 21, 2018
4-1BB enhancement of CAR T function requires NF-κB and TRAFsGongbo Li, Justin C Boucher, Hiroshi Kotani, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 15, 2022
Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting CellsJustin C Boucher, Bin Yu, Gongbo Li, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 14, 2019
Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting CellsBishwas Shrestha, Yongliang Zhang, Bin Yu, et al.
Scientific Reports|March 12, 2026
CD28 co-stimulatory domain enhances efficacy of CER T cell therapy compared to 4-1BB in an ovarian cancer mouse modelNolan J Beatty, Min Ma, Payal Goala, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cellsEmiliano Roselli, Justin C Boucher, Gongbo Li, et al.
Journal of Biomedical Science|July 11, 2024
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damageHiroshi Kotani, Hiroko Oshima, Justin C Boucher, et al.
Pageof 2